Clinical Trial Update: Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing how durable protection is after a single immunisation with GA2 sporozoites (CoGA-Rechallenge) for falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• GA2 sporozoites (GA2 sporozoites)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Malaria,Falciparum | Phase 1 | Status: NOT_YET_RECRUITING